Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
6.30
-0.16 (-2.48%)
At close: Apr 28, 2026, 4:00 PM EDT
6.30
0.00 (0.00%)
After-hours: Apr 28, 2026, 5:47 PM EDT
Taysha Gene Therapies Employees
Taysha Gene Therapies had 99 employees as of December 31, 2025. The number of employees increased by 26 or 35.62% compared to the previous year.
Employees
99
Change (1Y)
26
Growth (1Y)
35.62%
Revenue / Employee
$98,717
Profits / Employee
-$1,100,960
Market Cap
1.81B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Galapagos NV | 558 |
| Vericel | 398 |
| Syndax Pharmaceuticals | 298 |
| Harmony Biosciences Holdings | 293 |
| Innoviva | 159 |
| Pharvaris | 129 |
| Inhibrx Biosciences | 110 |
TSHA News
- 1 day ago - Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting - GlobeNewsWire
- 25 days ago - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Taysha Gene Therapies Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19 - GlobeNewsWire
- 3 months ago - These 20 stocks are strong choices for momentum investors - Market Watch
- 4 months ago - Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome - GlobeNewsWire
- 6 months ago - Taysha Gene Therapies Earnings Call Transcript: Q3 2025 - Transcripts